- Home
- BKYI vs ENSC Comparison
BKYI vs ENSC Comparison
Compare BKYI & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- ENSC
- Stock Information
- Founded
- BKYI 1993
- ENSC 2003
- Country
- BKYI United States
- ENSC United States
- Employees
- BKYI N/A
- ENSC N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- BKYI Technology
- ENSC Health Care
- Exchange
- BKYI Nasdaq
- ENSC Nasdaq
- Market Cap
- BKYI 5.3M
- ENSC 6.4M
- IPO Year
- BKYI 1997
- ENSC N/A
- Fundamental
- Price
- BKYI $0.94
- ENSC $2.11
- Analyst Decision
- BKYI
- ENSC
- Analyst Count
- BKYI 0
- ENSC 0
- Target Price
- BKYI N/A
- ENSC N/A
- AVG Volume (30 Days)
- BKYI 13.7M
- ENSC 166.0K
- Earning Date
- BKYI 11-13-2025
- ENSC 11-07-2025
- Dividend Yield
- BKYI N/A
- ENSC N/A
- EPS Growth
- BKYI N/A
- ENSC N/A
- EPS
- BKYI N/A
- ENSC N/A
- Revenue
- BKYI $6,911,148.00
- ENSC $7,413,722.00
- Revenue This Year
- BKYI $7.45
- ENSC N/A
- Revenue Next Year
- BKYI $23.29
- ENSC N/A
- P/E Ratio
- BKYI N/A
- ENSC N/A
- Revenue Growth
- BKYI N/A
- ENSC 415.58
- 52 Week Low
- BKYI $0.62
- ENSC $1.62
- 52 Week High
- BKYI $3.68
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- BKYI 64.67
- ENSC 42.50
- Support Level
- BKYI $0.73
- ENSC $2.03
- Resistance Level
- BKYI $1.97
- ENSC $2.26
- Average True Range (ATR)
- BKYI 0.12
- ENSC 0.22
- MACD
- BKYI 0.02
- ENSC -0.04
- Stochastic Oscillator
- BKYI 18.89
- ENSC 11.11
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.